Discussions of the share price/volume are very much on topic when it comes to any publicly traded stock.  

I can agree that the trial of JTB should be off topic.  

The tech discussions are great for people that understand tech really well, but for those that don’t, they can come away with a feeling that POET can’t miss.  That’s an inevitable, but nevertheless unfortunate side effect.